Recent Contributions

• Prices for COVID-19 vaccines are starting to come into focus
• Early Oxford-AstraZeneca coronavirus vaccine data 'encouraging,' scientists say
• 'Meaningless' FDA certificates are used to tout dubious face masks
• Remdesivir priced at more than $3,100 for a course of treatment
• Coronavirus pandemic brings hundreds of U.S. clinical trials to a halt